Company news
VivoSim Labs, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Organovo Achieves 3D Tissue Model for Crohn’s Disease
May 16, 2022
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
February 28, 2022
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
February 22, 2022
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
February 17, 2022
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
February 1, 2022
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
January 9, 2022
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 16, 2021
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
March 1, 2021
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 2, 2020
Organovo Announces One-for-Twenty Reverse Stock Split
August 16, 2020
Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics
April 6, 2020
Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt
March 30, 2020
Organovo Holdings, Inc. Reminds Stockholders About Adjourned Special Meeting of Stockholders
March 30, 2020
Organovo Holdings, Inc. Announces Adjournment of Special Meeting of Stockholders
March 26, 2020
Organovo Files Definitive Proxy Statement and Sends Letter to Stockholders
February 25, 2020
Organovo and Tarveda Therapeutics Announce Definitive Merger Agreement
December 15, 2019
Organovo Acknowledges Receipt of Proposal
October 1, 2019
Decks
- Investor Presentation (2026)
Investor deck · 22 slides · 2026